Capricorn Partners closes first healthtech fund

VC-firm raises 51 million to invest in digital health and hardware medical technologies.

Capricorn Partners is thrilled to announce the first closing at 51 million euros for its newest venture capital fund, Capricorn Healthtech Fund II, investing in healthcare transformers in digital health & medtech.

The Capricorn Healthtech Fund II will operate as a pan-European fund, targeting investment in 10-15 companies in the late seed to Series B stages. With initial investment tickets between 1 and 5 million euros, the fund will invest in traditional medical devices as well as novel health software platforms and applications. While the investment scope extends across Europe, we maintain a steadfast commitment to investing in our home-base, the Benelux region.

Enabling personalized and value-based healthcare
As populations continue to age and chronic diseases become more prevalent, the strain on healthcare systems intensifies. Personalization of health care is a key factor in reducing cost and improving service for patients. The European Commission's 2024 report on healthcare highlights that expenditure on health accounts for approximately 10 percent of the GDP in most EU countries.

Digital health and hardware medical technologies play an instrumental role in advancing value-based healthcare by enhancing patient outcomes and reducing costs. Technologies such as AI allow for the personalization of healthcare across the entire patient journey, from prevention and diagnosis to treatment. They enable healthcare providers to deliver tailored services more efficiently, improving the quality of care and patient satisfaction.

Capricorn Partners has over a decade of experience in scaling companies focused on personalized healthcare being one of the European pioneers investing in digital health & medical technologies. This has led to notable exits like Cartagenia, Bluebee and Sequana Medical and success stories like icometrix, which recently earned a reimbursement code for their radiology AI solution.

“With Capricorn Healthtech Fund II, we invest in healthcare transformers and facilitate their integration into mainstream healthcare practices, making healthcare more accessible and efficient”, says Filip Pintelon, Investment Partner Health at Capricorn Partners.

Read also: Katrin Geyskens (Capricorn Partners): The three major challenges of AI and how to address them

Related articles

PIA Group adds Argafin to advisory arm

The acquisition of Argafin is the latest addition to PIA Group’s advisory build-up, which began in 2023 with the addition of Aquis.

Be the Walmart, not the Kmart: what a barcode teaches private equity about AI

AI is changing not only what private equity firms invest in, but also how they invest. In the masterclass ‘Investing in the Age of AI’ at the Private Equity Summit Belgium, Wessel Wijtvliet, AI solutions lead at Loyens & Loeff and research fellow at the Faculty of Law of KU Leuven, offered a simple test: are you using AI to work a little faster, or to rebuild the way you work?

Top